(FOA)-Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats (UO1) Clinical Trials Not Allowed; May 1, 2020

 

Agency

Department of Health and Human Services

U.S. Food and Drug Administration

 

Description

FDA announces the availability of fiscal year (FY) 2020 funds to support the collection of data on antimicrobial use in companion animals. The funded data collection efforts are intended to 1) provide needed information on antimicrobial use in companion animals (specifically, dogs and cats); and 2) provide important information on data collection methodologies to help inform efforts to establish long-term strategies for collecting and reporting such data. The cooperative agreement will enable the collection of critical information to support the Center for Veterinary Medicine's goal to foster antimicrobial stewardship in veterinary settings. The data obtained will inform antimicrobial stewardship activities and support efforts to assess association between antimicrobial use practices and resistance.  

 

Goals and Objectives:

1. Applicant shall be able to develop and pilot a methodology to collect detailed information on antimicrobial drug use in dogs and cats. Information collected would include such information as antimicrobial drug name, established drug name, proprietary drug name, dose, duration of use, purpose of use, and quantity/extent of use.

2. Applicant’s methodology shall provide for annual collection and reporting of antimicrobial use information.  

3. Applicant shall be able to collect data in a manner that protects the identification of animal owners (clients), veterinarians, veterinary clinics and hospitals, etc, and shall protect against disclosure of any other confidential business information.

4. Applicant shall be able to produce an annual summary report of the data collected, including a detailed description of the data collection methodology.

5.  Applicant shall describe the extent to which the data collected is nationally representative for the species.

6.  Applicant shall describe strategies that would allow for expansion of data collection such that it could be nationally representative and continuous

 

Announcement Number:

RFA-FD-20-026

 

Closing Date:

May 1, 2020

 

Link to Full Announcement

https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-20-026.html

 

Contact Information

Susan Bright
(240)-402-5777

susan.bright@fda.hhs.gov